Pressure BioSciences Inc.’s (PBIO) Invention for

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
213
Pressure BioSciences Inc.’s (PBIO) Invention for “Hands-Free” High-Pressure Technology Sample Prep Workflow Platform Earns Key US Patent

- Novel flow-through invention offers critical enablement for future system design strategies for groundbreaking biotherapeutics research, as well as drug discovery & development
- Development of next generation Barocycler instruments to allow “hands-free” sample processing that will increase accuracy, reduce costs and avoid contamination
- Global sample preparation market projected to reach $8.2 billion by 2024
- Global proteomics market projected to reach $21.87 billion in 2021
- PBIO’s innovative ultra-shear pressure-based platform technology (UST) being used in federally-funded food safety and preservation development program at Ohio State University
- Potential applications for UST include pharmaceuticals, nutraceuticals, food and beverages, lubricants, paints and cosmetics

Pressure BioSciences Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, has added another patent to its intellectual property portfolio, bringing the total to 21 patents. Issued as U.S. Patent 9995661 and titled “Flow-through High Hydrostatic Pressure Microfluidic Sample Preparation Device and Related Methods Therefor,” this new patent is a significant development in the company’s strategic plan to develop automated “hands-free” sample handling for the next generation of PBI’s high-pressure sample preparation platform systems, a news release states (http://nnw.fm/1gOh3).

The global sample preparation market is projected to reach $8.2 billion by 2024, according to a report by TransparencyMarketResearch (http://nnw.fm/u1I4Y). Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument system, which can be used to exquisitely control the sample preparation process. Based on the company’s patented and enabling pressure cycling technology (PCT) platform, over 300 Barocycler systems have been installed in approximately 200 academic, government, pharmaceutical and biotech research laboratories worldwide. These laboratories use the PCT instrument system for multiple applications, including the preparation of samples for biomarker and target discovery, soil & plant biology, anti-bioterror and forensics studies. There are over 100 independent scientific publications highlighting the advantages of the PCT system in such studies, many from worldwide key opinion leaders.

“This long-anticipated patent is a very important development for the Company on multiple fronts, and the timing of its issuance could not be better,” Dr. Alexander Lazarev, PBI’s vice president of research and development, stated in the release. “This invention also enables a unique capability for maintaining high pressure in a flow-through format (rather than the current batch processing), which we expect will facilitate the development of new, automated continuous process monitoring tools applicable to diverse segments of the life sciences industry.”

The invention’s novel flow-through concept offers critical enablement for future system design strategies for epitope characterization, Lazarev noted. An epitope is the antibody binding site on an antigen capable of eliciting an immune response. “This is an emerging area in development and production of biotherapeutics that could revolutionize personalized therapy for numerous medical conditions, including autoimmune diseases and a variety of rare medical disorders,” Lazarev explained.

PBI’s latest, patented invention will allow for further development of a much sought-after, hands-free, automated workflow, providing valuable enhancements in efficiencies, throughput and contamination avoidance for the company’s instrument and consumable product lines, Richard T. Schumacher, president and CEO of PBI, added.

“We also believe this invention will accelerate our expansion into larger scale applications in multiple major business segments for the Company, particularly in the rapidly growing field of proteomics research,” Schumacher said. “Growth in proteomics and other additional areas should further cement and expand market acceptance and recognition for PBI’s innovative and enabling pressure-based platform technologies and spur concomitant growth in revenue and shareholder value.”

According to a market report by Research and Markets, the worldwide biopharmaceuticals market in 2014 reached a valuation of $160.44 billion.

Pressure BioSciences is forecast to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022, according to a Zacks Research Report issued on July 26, 2018 (http://nnw.fm/F3GhM). In the Zacks Small-Cap Research Report, the company’s fair value for PBIO shares was raised to $12/share from a previous $10/share. Zacks’ optimism regarding Pressure BioSciences is tied to a number of recent achievements and collaborative research programs, expansion of the company’s sales and marketing capabilities and a newly established multinational co-marketing partner, ISS Inc.

The future looks bright for the company based on the expected growth in sales of its PCT-based instrument systems. PBI’s revenue should be additionally impacted by the development of its newest high-pressure technology platform, ultra shear technology (UST). UST offers the potential to produce highly stable, clean and cost-effective nanoemulsions that facilitate the production of food products with enhanced shelf lives without the need for chemicals or preservatives, as detailed in a recent article (http://nnw.fm/U0P5r). The company believes that its UST technology platform can be applied across a multitude of industries seeking to satisfy consumer demand for chemical- and preservative-free food products that have longer shelf-lives, greater safety and do not require refrigeration until opened. These areas include pharmaceuticals, nutraceuticals, cosmetics, paints and industrial lubricants.

For more information, visit the company’s website at www.PressureBioSciences.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Pressure Biosciences (PBIO) Stock Research Links

PBIO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 61

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 72

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 35

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 94

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 79

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 120

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
Early Home Care Signals Families Should Not Ignore

Updated Category News Views 46

A pill organizer sitting untouched can say more than a family conversation ever will. Jay Mann of Amada Senior Care in Richmond points to a hard truth in HelloNation's Nov. 20, 2026 article: the need for in-home support often arrives quietly, disguised as little breaks in routines that everybody would rather wave away. This is not a matter for armchair diagnosis, and...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 31

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 60

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
.com/blog/news?page=2">More News Articles